TH159929B - New DGAT2 inhibitors - Google Patents

New DGAT2 inhibitors

Info

Publication number
TH159929B
TH159929B TH1601002924A TH1601002924A TH159929B TH 159929 B TH159929 B TH 159929B TH 1601002924 A TH1601002924 A TH 1601002924A TH 1601002924 A TH1601002924 A TH 1601002924A TH 159929 B TH159929 B TH 159929B
Authority
TH
Thailand
Prior art keywords
new
dgat2 inhibitors
compound
dgat2
inhibitors
Prior art date
Application number
TH1601002924A
Other languages
Thai (th)
Other versions
TH1601002924A (en
TH159929A (en
Original Assignee
อีไล ลิลลี่ แอนด์ คัมปะนี
Filing date
Publication date
Application filed by อีไล ลิลลี่ แอนด์ คัมปะนี filed Critical อีไล ลิลลี่ แอนด์ คัมปะนี
Publication of TH1601002924A publication Critical patent/TH1601002924A/en
Publication of TH159929B publication Critical patent/TH159929B/en
Publication of TH159929A publication Critical patent/TH159929A/en

Links

Abstract

การประดิษฐ์นี้ให้สารประกอบของสูตรด้านล่าง (สูตรเคมี) ที่ซึ่ง R คือ H หรือ -CH3; วิธีการรักษาผู้ป่วยสำหรับภาวะไตรกลีเซอไรด์ในเลือดสูงเเละ โรคหลอดเลือดหัวใจที่รวมถึงภาวะไลปิดในเลือดผิดปกติ และภาวะหลอดเลือดเเดงเเข็งเเละ กระบวนการสำหรับการเตรียมสารประกอบ This invention gives the compound of the below formula (chemical formula) where R is H or -CH3; Treatment methods for high blood triglycerides and Cardiovascular disease that includes abnormal lipid in the blood And thrombocytopenia Process for compound preparation

TH1601002924A 2014-11-19 New DGAT2 inhibitors TH159929A (en)

Publications (3)

Publication Number Publication Date
TH1601002924A TH1601002924A (en) 2017-02-07
TH159929B true TH159929B (en) 2017-02-07
TH159929A TH159929A (en) 2017-02-07

Family

ID=

Similar Documents

Publication Publication Date Title
DK3204015T3 (en) COMPOUNDS AND METHODS FOR INHIBITATION OF HAO1 GENE EXPRESSION (HYDROXYIC ACID OXIDASE 1 (GLYCOLATE OXIDASE))
FR3046933B1 (en) NLRP3 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
EA201691135A1 (en) NEW GLUTAMINASE INHIBITORS
IL253945A0 (en) Kdm1a inhibitors for the treatment of disease
MA43135A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
EA201792535A1 (en) HETEROCYCLIC AMIDES AS KINAZ INHIBITORS
EA201692079A1 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1
CR20200362A (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS (Divisional 2016-0395)
MA50635A (en) NEW BICYCLIC COMPOUNDS AS INHIBITORS OF AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID PRODUCTION
EA201691421A1 (en) HETEROARILES AND THEIR APPLICATION
EA201591889A1 (en) 6- (5-HYDROXY-1H-PYRAZOL-1-IL) NICOTINAMIDE PHD INHIBITORS
IL255764B (en) Autotaxin inhibitors selected from derivatives of 1-alkyl-1hpyrazol-4-yl-1h-indol-3-yl-thio-2-benzoic (or picolinic) acid and use thereof for treating diseases
DK3157534T3 (en) ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
IL254266B (en) Glucosylceramide synthase inhibitors for the treatment of diseases
DOP2016000120A (en) NEW DGAT2 INHIBITORS
DK3164394T3 (en) GLS1 INHIBITORS FOR TREATMENT OF DISEASES
ZA201707822B (en) Process for the biological production of methacrylic acid and derivatives thereof
PT3297628T (en) Calcineurin inhibitors of the setron family for the treatment of hearing loss
ZA201803942B (en) Novel processes for preparation of integrase inhibitor
MA45973A (en) BTK INHIBITOR COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
MA39927A (en) GLYT1 INHIBITORS FOR THE TREATMENT OF BLOOD DISORDERS
EA201790830A1 (en) ALDOSTERONSYNTASE INHIBITORS
DE112015002229A5 (en) Formulations for the treatment of hyperthyroidism
PT3394069T (en) Process for the preparation of hiv integrase inhibitors
TH159929B (en) New DGAT2 inhibitors